Daniel Friedman
@Corbin Capital Partners, L.p.
Latest period2024 - Q3ReportedManaged Assets$79.119BTotal holdings29
Assets growth rate52.58%Assets growth rate (2-Q avg)20.13%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Corbin Capital Partners, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.
Assets under management
The assets under management (AUM) of Corbin Capital Partners, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 79.119B in assets, with a quarterly growth rate of 52.58% and a 2-quarter average growth rate of 20.13%. The portfolio is managed by Daniel Friedman, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
EDREndeavor Group Hldgs Inc
| 45.79% | $36.228B 1.268M shares@ $28560.01 avg price | New Position |
CORZCore Scientific Inc New
| 15.4% | $12.184B↑ Call 1.027M shares@ $11860.01 avg price | Increased 31.53% |
HYGIshares Tr
| 13.15% | $10.403B 129,550 shares@ $80300.0 avg price | New Position |
BKLNInvesco Exch Traded Fd Tr Ii
| 12.82% | $10.138B 482,509 shares@ $21010.0 avg price | New Position |
ABUSArbutus Biopharma Corp
| 4.16% | $3.285B 853,304 shares@ $3850.0 avg price | |
EVLVEvolv Technologies Hldngs In
| 3.14% | $2.479B 612,000 shares@ $4050.0 avg price | New Position |
ROIVRoivant Sciences Ltd
| 2.21% | $1.741B 150,886 shares@ $11540.0 avg price | Decreased -11.7% |
SRGSeritage Growth Pptys
| 1.26% | $996.118M 214,219 shares@ $4650.0 avg price | Decreased -55.88% |
SLNOSoleno Therapeutics Inc
| 0.75% | $589.976M 11,685 shares@ $50490.03 avg price | New Position |
HIPOHippo Hldgs Inc
| 0.52% | $405.12M 24,000 shares@ $16880.0 avg price |